Literature DB >> 15955411

Protective effect of serofendic acid on glutamate-induced neurotoxicity in rat cultured motor neurons.

Toshiaki Kume1, Yuko Kawai, Kohei Yoshida, Tomoki Nakamizo, Rie Kanki, Hideyuki Sawada, Hiroshi Katsuki, Shun Shimohama, Hachiro Sugimoto, Akinori Akaike.   

Abstract

We have previously reported that a sulfur-containing neuroprotective substance named serofendic acid was purified and isolated from lipophilic extract of fetal calf serum (FCS). In the present study, we investigated the effect of serofendic acid on glutamate neurotoxicity using embryonic rat spinal cord culture. When cultures were exposed to glutamate (20 microM) with a glutamate transporter inhibitor L-trans-pyrrolidine-2,4-decarboxylate (PDC; 40 microM) for 24 h, motor neurons were injured through both N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methylisoxazole/kainate receptors. This glutamate neurotoxicity was attenuated by nitric oxide (NO) synthase inhibitors. Serofendic acid (0.1-5 microM) prevented glutamate neurotoxicity in a concentration-dependent manner. S-Nitrosocysteine (SNOC; 10 microM), an NO donor, induced motor neuronal death. Serofendic acid (5 microM) also prevented SNOC-induced neurotoxicity. These results indicate that serofendic acid protects cultured motor neurons from glutamate neurotoxicity by reducing the cytotoxic action of NO.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15955411     DOI: 10.1016/j.neulet.2005.04.015

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Stereoselective semi-synthesis of the neuroprotective natural product, serofendic acid.

Authors:  Dimitri Perusse; Michael J Smanski
Journal:  Medchemcomm       Date:  2019-04-23       Impact factor: 3.597

2.  Serofendic acid protects from iodinated contrast medium and high glucose probably against superoxide production in LLC-PK1 cells.

Authors:  Osamu Kitamura; Kazuhide Uemura; Hisayo Kitamura; Hachiro Sugimoto; Akinori Akaike; Takahiko Ono
Journal:  Clin Exp Nephrol       Date:  2008-10-01       Impact factor: 2.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.